Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine Receptors
- 1 January 2011
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 14 (1) , 65-76
Abstract
Modification of α-conotoxin frameworks through cyclization via an oligopeptide linker has previously been shown as an effective strategy for improving in vivo stability. We have extended this strategy by investigating cyclic analogs of α-conotoxin AuIB, a selective α 3 β 4 nicotinic acetylcholine receptor (nAChR) antagonist, to examine a range of oligopeptide linker lengths on the oxidative formation of disulfide bonds, activity at nAChRs, and stability to degradation by chymotrypsin. Upon nondirected random oxidation, the ribbon isomer formed preferentially with the globular isomer occurring as a minor by-product. Therefore, a regioselective disulfide bond forming strategy was used to prepare the cAuIB-2 globular isomer in high yield and purity. The cAuIB-2 globular isomer exhibited a threefold decrease in activity for the α 3 β 4 nAChR compared to wild-type-AuIB, although it was selective for α 3 β 4 over α 7 and α 4 β 2 subtypes. On the other hand, the cAuIB-2 ribbon isomer was shown to be inactive at all three nAChR subtypes. Nonetheless, all of the cyclic analogs were found to be significantly more stable to degradation by chymotrypsin than wild-type AuIB. As such, the cAuIB-2 globular isomer could constitute a useful probe for studying the role of the α 3 β 4 nAChR in a range of in vivo experimental paradigms. Antioxid. Redox Signal. 14, 65–76.Keywords
This publication has 45 references indexed in Scilit:
- Synthetic α-Conotoxin Mutants as Probes for Studying Nicotinic Acetylcholine Receptors and in the Development of Novel Drug LeadsToxins, 2010
- A Synthetic Combinatorial Strategy for Developing α-Conotoxin Analogs as Potent α7 Nicotinic Acetylcholine Receptor AntagonistsJournal of Biological Chemistry, 2010
- Establishing regiocontrol of disulfide bond isomers of α‐conotoxin ImI via the synthesis of N‐to‐C cyclic analogsPeptide Science, 2009
- Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptorsActa Pharmacologica Sinica, 2009
- Rational Design of α-Conotoxin Analogues Targeting α7 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 2009
- α-Selenoconotoxins, a New Class of Potent α7 Neuronal Nicotinic Receptor AntagonistsJournal of Biological Chemistry, 2006
- Conotoxins as Research Tools and Drug LeadsCurrent Protein & Peptide Science, 2005
- Converting a Peptide into a Drug: Strategies to Improve Stability and BioavailabilityCurrent Medicinal Chemistry, 2002
- Nuclear Magnetic Resonance Solution Conformation of α-Conotoxin AuIB, an α3β4 Subtype-selective Neuronal Nicotinic Acetylcholine Receptor AntagonistJournal of Biological Chemistry, 2000
- Chemoselective backbone cyclization of unprotected peptidesChemical Communications, 1997